A B S T R A C T Identifying posterior pituitary hormones in body fluids or neurohypophysial extracts was heretofore partially achieved by using pharmacologic potency ratios or semispecific inactivation by thioglycolate or enzymes. Production of antisera against oxytocin and lysine-vasopressin has prompted us to test their specificity against lysine-vasopressin, arginine-vasopressin, arginine-vasotocin, and oxytocin. In ethanol anesthetized rats, antidiuretic and milk-ejection activities were assayed for each peptide-antiserum combination after 0, 30, 60, and 90 min of incubation. Results indicate that (a) oxytocin antiserum inactivates oxytocin, but not arginine-vasopressin, lysine-vasopressin, or arginine-vasotocin; vasopressin antiserum inactivates arginine-vasopressin and lysine-vasopressin, but neither oxytocin nor arginine-vasotocin; (b)) an identifiable antigenic site exists for each hormone; (c) relatively specific identifications of natural neurohypophysial peptides are possible using antisera and bioassays; (d) this method is promising for identifying neurohypophysial peptides in body fluids and pituitary extracts; and (e) active and passive immunization against oxytocin and vasopressin may increase our understanding of their physiologic functions.
INTRODUCTION
E.ccept for the Suina, all mammals so far studied secrete 8-arginine-vasopressin (AVP) and oxytocin from their posterior pituitary glands. In most members of the Suina, 8-lysine-vasopressin (LVP) replaces AVP as the antidiuretic hormone. Among nonmammalian vertebrates, almost all secrete 8-arginine-oxytocin (argininevasotocin, AVT) as well as oxytocin or peptides closely resembling oxytocin (1) .
These neurohypophysial hormones are produced in hypothalamic nuclei, transported via axons to the posteReceived for publication 2 September 1969 and in revised form 5 December 1969. rior pituitary gland for storage and are released from there into the systemic circulation. Their basic structures are very similar, differing only in the amino acid residues at positions 3 and 8. Therefore, it is not surprising that they have similar pharmacologic effects such as antidiuretic, milk-ejection, oxytocic, avian vasodepressor, and rat vasopressor activities, or that these effects are absolutely and relatively different depending upon the structure of the peptide (2) .
Naturally occurring substances other than the neurohypophysial hormones can cause some or all of the aforementioned pharmacologic effects. These substances are histamine, catecholamines, 5-hydroxytryptamine, acetylcholine, angiotensin, bradykinin, and other nonspecific peptides (3, 4) . Hence, to identify tentatively a neurohypophysial peptide by its pharmacologic actions, one must use a highly purified preparation or one with so much of the hormone present that other contaminating, extraneous, pharmacologically active substances can be diluted out of consideration. However, so little hormone is present in body fluids that neither of these techniques is entirely satisfactory or possible.
For absolute identification of a neurohypophysial peptide, chemical identification of all the amino acid residues and their sequence are required, and ultimate proof requires synthesis of the proposed peptide molecule and demonstration of biological activity identical to that of the natural hormone (5 which acts at the glycinamide-leucine bond. AVP, LVP, and AVT, but not oxytocin, are destroyed by trypsin digestion, which acts at the glycinamide-arginine or glycinamide-lysine bond. Oxytocin, AVP, LVP, and AVT are inactivated by incubation with each of the following: the oxytocinase-vasopressinase system of human pregnancy plasma, tyrosinase, and thioglycolate. These agents act by disrupting the peptide bonds between cystine and tyrosine, by the probable formation of an O-quinone group on tyrosine, and by disruption of the disulfide bond between the two cystine half-moieties, respectively (6) . Although considerable evidence regarding structure can be adduced from such destruction experiments, a specific identification is never possible. Also, inadequate amounts of material are present for such identification experiments, especially when analyzing biological fluids such as blood plasma or urine. For these reasons simpler and more specific means of identifying neurohypophysial hormones in body fluids have been sought. Recently, antisera against LVP (7) and oxytocin (8) have been produced in rabbits and used in immunoassays for the estimation and identification of neurohypophysial hormones.
In some preliminary studies (9-11) it was found that these antisera abolished the activities of their corresponding antigenic hormones, and it also appeared that their inactivating properties were rather potent and specific. Therefore, it seemed important to evaluate the degree of structural specificity of these antisera against different neurohypophysial octapeptide substrates. Should high specificity be demonstrated, a quick and accurate test for tentatively identifying neurohypophysial peptides might be achieved.
In the present study we have established that rabbit antisera prepared against LVP and oxytocin are potent inactivators of their corresponding antigenic hormones. The specificity of these antisera was demonstrated by the absence of cross-reaction, i.e., LVP antiserum could not inactivate oxytocin and oxytocin antiserum could not inactivate LVP. Neither antiserum abolished the antidiuretic or milk-ejection activities of the structurally similar AVT.
METHODS
Bioassays. For the measurement of antidiuretic activity, ethanol anesthetized albino rats (160-230 g) under water diuresis were used. The test solutions were injected intravenously (injection volume 0.5 ml) and changes in urine flow were related to the base line flow, (average of preinjection and postresponse flow). The lowest assayable dose in this bioassay is 2.5-5 ,uU/dose of AVP. This assay procedure has been previously described in detail (12) .
For the measurement of milk-ejection activity in ethanolanesthetized lactating rats, a teat duct of an abdominal mammary gland was cannulated. Ipsilateral injections (injection volume 0.2 ml) were given retrograde via the femoral artery and changes in intraductal pressure were recorded. In this assay the maximal sensitivity to oxytocin is 2.5-5 ,uU/dose. The assay procedure used has already been described (9) .
Hormone substrates. Natural AVP 1 (200, 500, and 1000
,uU/ml), synthetic LVP 2 (200 and 400 ,AU/ml), synthetic AVT2 (1 ng/ml), and synthetic oxytocin2 (50, 100, and 200 ,U/ml) were separately dissolved in 0.9% NaCl-0.1 M phosphate buffer, pH 7.4, and served as substrates for all incubations. Inactivating agents. As inactivating agents, 0.01 ml of 8-lysine-vasopressin antiserum,3 0.01 ml of oxytocin antiserum,4 or 0.1 ml of human near-term pregnancy plasma were used for each milliliter of substrate incubation medium. Equal volumes of normal rabbit plasma or plasma from nonpregnant women incubated with corresponding substrates served as controls.
For the production of antibodies against oxytocin and LVP, the hormones are usually coupled in vitro with carbodiimide in order to facilitate their aggregation to serum proteins and thus to enhance the formation of antibodies (7, 13, 14) . Then the antigenic octapeptide is mixed with an equal volume of complete Freund's adjuvant and the emulsion is injected in the footpads of rabbits. In general, weekly doses of 02 mg of either oxytocin or LVP given with complete Freund's adjuvant for 3-6 wk will cause production of the respective antibodies. Additional injections in 4-to 8-wk intervals with similar hormone doses will maintain antibody formation and occasionally increase serum antibody titers.
Human pregnancy plasma and plasma of pregnant anthropomorphous apes contain a specific oxytocinase-vasopressinase enzyme system which is thought to be produced in the syncytial cells of the trophoblast. This plasma enzyme(s) increases as pregnancy advances. It is not excreted in the urine and it disappears from the bloodstream within 2-3 wk after delivery. The physiologic function of this enzyme system is not understood (6) .
Inactivating capacities of these agents are shown in Figs. 1 and 2, indicating that 0.01 ml of either. vasopressin or oxytocin antiserum was able to inactivate 200 ,U/ml of AVP or oxytocin, respectively, within 15-20 min; 0.05 ml of human pregnancy plasma was able to inactivate the antidiuretic effect of 200 ,U/ml of vasopressin within 15 min of incubation. With 200 AU/ml of oxytocin as incubation medium, 0.1 ml of human pregnancy plasma was able to destroy the milk-ejection activity after 60 min of incubation.
Incubation experiments. After 30, 60, and 90 min incubation of the various mixtures at 37°C, they were tested for antidiuretic and milk-ejection activities. These activities 'Purified bovine 8-arginine-vasopressin (52 pressor units/ mg) was kindly supplied by Dr. F. Armstrong, Parke, Davis In another series of experiments 1 ml of a 1000 uU/ml solution of AVP was incubated with 0.1 ml of vasopressin antiserum and 1 ml of a 1.0 ng/ml solution of AVT was incubated separately with 0. thetized with sodium pentobarbital during an intravenous infusion of acetylcholine. The antidiuretic and milk-ejection activities correspond to 109 ±18,U/ml of AVP and 69 ±8 MU/ml of oxytocin, respectively. Aliquots of this CSF were separately incubated for 30 min with 0.01 ml of oxytocin antiserum, vasopressin antiserum, and 0.1 ml of pregnancy plasma and tested again for antidiuretic and milkejection activity. (b) Blood plasma from a dog anesthetized with sodium pentobarbital was obtained during hemorrhagic shock. Plasma antidiuretic and milk-ejection activities were found corresponding to 368 ±27 MU/ml of AVP and 62 +12 MU/ml of oxytocin, respectively. Separate aliquots of plasma were incubated for 30 min with 0.01 ml of oxytocin antiserum, vasopressin antiserum, and 0.1 ml of pregnancy plasma and tested again for antidiuretic and milk-ejection activity. (c) A diluted rat pituitary extract with antidiuretic and milk-ejection activities corresponding to 70 ±+10 MU/ml of AVP and 30 ±9 MU/ml of oxytocin, respectively, was separately incubated with 0.01 ml of either oxytocin or vasopressin antiserum for 30 min at 37°C and then reassayed.
RESULTS
Incubation studies with vasopressin antiserum as inactivating agent. LVP antiserum (0.01 ml) completely blocked the antidiuretic and milk-ejection activity of AVP and LVP after 30 min of incubation (Table I and Fig. 3 ). With 0.1 ml of LVP antiserum, the activity of 1000 MU/ml of AVP was abolished after 30 min of incubation.
Neither 0.01 ml nor 0.1 ml of LVP antiserum could inactivate the antidiuretic activity of AVT or the milkejection activity of AVT or oxytocin ( [4](P > 0. 4) [5](P > 0.5) [7] [4](P < 0.01) [5] (P < 0.01) 100 <25 100 <25 <25 [3] [3](P <0.02) [6] [3](P <0.05) [3] (P <0.05) 100 13 ±13 100 26 ±13 <25 [4] [4](P < 0.01) [7] [3](P < 0.05) [5] (P < 0.01) 100 8 ±8 100 30 ±13 <25 [6] [6](P <0.01) [4] [3](P <0.01) [4] (P <0.01) [3] [4] [5] . The complete inactivation of the milk-ejection activity of 1000 iU of arginine vasopressin with 8-lysine-vasopressin antiserum indicates that the purified beef vasopressin contained very little or no oxytocin. Since the milk-ejection method is sensitive to 2.5-5 mU of oxytocin per dose, the oxytocin impurity of the 1000 /AU of purified beef vasopressin must lie below 12.5-25 &U. Incubation studies with oxytocin antiserum as inactivating agent. After 30-90 min incubation of AVP, LVP, and AVT with 0.01 ml or 0.1 ml of oxytocin antiserum, no changes in hormonal activities were observed as compared with the unincubated control solutions. With 0.01 ml of oxytocin antiserum the milkejection activity of 50 uU/ml oxytocin was completely abolished. In three out of four experiments with 100
;&U/ml and in five out of six experiments with 200 i&U/ ml oxytocin, complete inactivation occurred after 30 min of incubation (Table I, Fig. 5 ).
Incubation studies with pregnancy plasma as inactivating agent. Within 30-60 min of incubation with pregnancy plasma the antidiuretic and milk-ejection activities of AVP, LVP, AVT, and oxytocin were all destroyed (Table I, Figs. 3 and 4) .
Characterization of neurohypophysial hormone-like activities in biologic fluids and hypophysial extracts. (a) The antidiuretic activity of CSF was eliminated after 30 min incubation with pregnancy plasma and Identification of oxytocin and vasotocin (rat milk-ejection assay). Incubation study with oxytocin and arginine-vasotocin as substrates and antisera as inactivating agents. Oxytocin antiserum blocks the milk-ejection activity of oxytocin but not that of vasotocin. Vasopressin antiserum does not suppress the milk-ejection activity of oxytocin.
LVP antiserum, but not with oxytocin antiserum. The milk-ejection activity of the CSF was abolished by incubation with pregnancy plasma and oxytocin antiserum but not with LVP antiserum (Fig. 6) . Therefore, we concluded that the CSF contained AVP and oxytocin. (b) The antidiuretic and milk-ejection activities of the plasma from a dog in hemorrhagic shock were destroyed after incubation with LVP antiserum and pregnancy plasma (Fig. 7) . Incubation of the plasma with oxytocin antiserum did not influence the antidiuretic or milk-ejection activities. We therefore assume that the measured activities were due entirely or predominantly to AVP. (c) The antidiuretic and milkejection activities of the diluted rat pituitary extract were abolished only after separate incubations with LVP and oxytocin antisera, respectively. In Fig. 8 the selective suppression of the extract's milk-ejection activity after incubation with oxytocin antiserum is depicted; after incubation with LVP antiserum, the milk-ejection activity was not significantly diminished. DISCUSSION Chemical identification of vasopressin or oxytocin in extracted, purified, and concentrated test material is required for absolute proof of the existence of any neurohypophysial hormone (5) . Since the content of neurohypophysial hormones extracted from body fluids is insufficient by present-day techniques to identify these hormones chemically, crude biologic procedures have generally been utilized.
In the present study, it was demonstrated that oxytocin, the two vasopressins, and AVT could be differentiated one from the other by incubation with vasopressin and oxytocin antisera. However, it was impossible to differentiate the two mammalian antidiuretic hormones, AVP and LVP, one from the other. With the exception of AVP, the activity of which is blocked by antibodies produced against lysine vasopressin, it was found in confirmation of earlier reports (8, 13 ) that antisera against vasopressin or oxytocin do not cross-react. In addition, the structurally similar AVT resisted both of these antisera even when tenfold concentrations of antisera were employed. Because LVP antiserum blocks the biologic activity of AVP and LVP, but not AVT or oxytocin, it seems that the 3-phenylalanine moiety in the ring forms a key portion of the antigenic site of the molecule and is responsible for the specificity of this antiserum. When 3-phenyl- analogues and antisera to study, these questions shourd be readily answerable.
Use of antisera and biological assays does allow one to conclude that, tentatively, a biologic solution contains a definite amount of a specific neurohypophysial hormone. As demonstrated in Fig. 8 , the milk-ejection activity of the rat pituitary extract was eliminated after incubation with oxytocin antiserum thus indicating that it contained oxytocin in amounts exceeding 12.5-25 'OU/ml.
The tentative identification of AVP and oxytocin in CSF by using antisera and antidiuretic and milkejection assays provides evidence for the first time that both neurohypophysial hormones can be released into the CSF. Likewise, by incubating oxytocin and vasopressin antisera with plasma from hemorrhaged dogs, we have confirmed the observations of others (15) which suggest that under the stimulus of hemorrhage vasopressin but little or no oxytocin is released from the posterior pituitary gland into the circulation.
The rather specific behavior of these antisera suggests their potential use for the biologic identification of naturally occurring octapeptides. Despite much research it is still not clear which oxytocin-like peptides or combinations of them are secreted by various nonmammalian species (1, 16 
